MSON : Summary for MISONIX, Inc. - Yahoo Finance

U.S. Markets open in 1 hr 21 mins

Misonix, Inc. (MSON)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.85-0.20 (-1.81%)
At close: 4:00PM EST
People also watch
MOCOIRIXMLABMTSCKEQU
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close11.05
Open0.00
Bid10.50 x 1000
Ask11.50 x 500
Day's Range10.75 - 11.20
52 Week Range3.83 - 11.20
Volume12,466
Avg. Volume22,893
Market Cap84.51M
Beta0.35
PE Ratio (TTM)27.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire16 days ago

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Misonix, Inc. - MSON

    NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Levi & Korsinsky announces it has commenced an investigation of Misonix, Inc. (NASDAQ: MSON) concerning possible breaches of fiduciary duty by the board of ...

  • PR Newswirelast month

    Stavros G. Vizirgianakis Appointed President and CEO of Misonix, Inc.

    FARMINGDALE, N.Y., Dec. 19, 2016 /PRNewswire/ -- Misonix, Inc. (MSON), a leading provider of ultrasonic surgical tools, announced today the appointment of Stavros G. Vizirgianakis as the Company's President and Chief Executive Officer effective immediately. Mr. Vizirgianakis has served as interim Chief Executive Officer since September 2, 2016, and has served as a member of the Misonix Board of Directors since May 2013. Separately, the Company announced the resignation of T. Guy Minetti from the Board of Directors after leading the Board process to recruit Mr. Vizirgianakis to accept the CEO role.

  • PR Newswire2 months ago

    Misonix Reports Nasdaq's Acceptance of Its Plan to Regain Listing Compliance

    FARMINGDALE, N.Y., Nov. 28, 2016 /PRNewswire/ -- Misonix, Inc. (MSON) ("Misonix" or the "Company"), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced that The Nasdaq Stock Market LLC ("Nasdaq") has accepted the Company's plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) which would permit the continued listing of Misonix common stock on the Nasdaq Global Market.